155 related articles for article (PubMed ID: 3443654)
1. Characterization and quantification of PAF-acether (platelet-activating factor) as a heptafluorobutyrate derivative of 1-O-alkyl-2-acetyl-sn-glycerol by capillary column gas chromatography with electron-capture detection.
Bossant MJ; Farinotti R; Mencia-Huerta JM; Benveniste J; Mahuzier G
J Chromatogr; 1987 Dec; 423():23-31. PubMed ID: 3443654
[TBL] [Abstract][Full Text] [Related]
2. Capillary gas chromatography and tandem mass spectrometry of paf-acether and analogs: absence of 1-O-alkyl-2-propionyl-sn-glycero-3-phosphocholine in human polymorphonuclear neutrophils.
Bossant MJ; Farinotti R; De Maack F; Mahuzier G; Benveniste J; Ninio E
Lipids; 1989 Feb; 24(2):121-4. PubMed ID: 2755300
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of platelet-activating factor by high-performance liquid chromatography with fluorescent detection.
Mita H; Yasueda H; Hayakawa T; Shida T
Anal Biochem; 1989 Jul; 180(1):131-5. PubMed ID: 2817335
[TBL] [Abstract][Full Text] [Related]
4. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel scintillation proximity radioimmunoassay for platelet-activating factor measurement: comparison with bioassay and GC/MS techniques.
Sugatani J; Lee DY; Hughes KT; Saito K
Life Sci; 1990; 46(20):1443-50. PubMed ID: 2111868
[TBL] [Abstract][Full Text] [Related]
6. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor in normal rat uterus.
Yasuda K; Satouchi K; Saito K
Biochem Biophys Res Commun; 1986 Aug; 138(3):1231-6. PubMed ID: 3753495
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of lyso-platelet activating factor molecular species from human neutrophils by mass spectrometry.
Haroldsen PE; Clay KL; Murphy RC
J Lipid Res; 1987 Jan; 28(1):42-9. PubMed ID: 3104521
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometry.
Shindo K; Hashimoto Y
Drugs Exp Clin Res; 1991; 17(7):343-9. PubMed ID: 1794300
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
11. Human neutrophil platelet-activating factor: molecular heterogeneity in unstimulated and ionophore-stimulated cells.
Ramesha CS; Pickett WC
Biochim Biophys Acta; 1987 Sep; 921(1):60-6. PubMed ID: 3113489
[TBL] [Abstract][Full Text] [Related]
12. Isotopic exchange during derivatization of platelet activating factor for gas chromatography-mass spectrometry.
Haroldsen PE; Gaskell SJ; Weintraub ST; Pinckard RN
J Lipid Res; 1991 Apr; 32(4):723-9. PubMed ID: 1856615
[TBL] [Abstract][Full Text] [Related]
13. The enantiomer and the positional isomer of platelet-activating factor.
Tence M; Coëffier E; Polonsky J; Benveniste J
Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
[TBL] [Abstract][Full Text] [Related]
14. Isolation, chemical characterization, and subcellular distribution of 1-O-alkyl-2-acetyl-sn-glycerol in Tetrahymena pyriformis cells.
Tellis C; Tsoukatos DC; Lekka ME
J Biochem; 1996 Apr; 119(4):823-7. PubMed ID: 8743588
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
[TBL] [Abstract][Full Text] [Related]
16. Effect of 1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) on leukocytes I. Analysis of the in vitro migration of human neutrophils.
Czarnetzki BM; Benveniste J
Chem Phys Lipids; 1981 Dec; 29(4):317-26. PubMed ID: 7318049
[TBL] [Abstract][Full Text] [Related]
17. Observations on the critical micellar concentration of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine and a series of its homologs and analogs.
Kramp W; Pieroni G; Pinckard RN; Hanahan DJ
Chem Phys Lipids; 1984 May; 35(1):49-62. PubMed ID: 6744496
[TBL] [Abstract][Full Text] [Related]
18. Determination of platelet-activating factor and alkyl-ether phospholipids by gas chromatography-mass spectrometry via direct derivatization.
Balazy M; Braquet P; Bazan NG
Anal Biochem; 1991 Jul; 196(1):1-10. PubMed ID: 1888023
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of paf-acether. XVI. Acetyltransferase specificity determines composition of paf-acether molecular species in human polymorphonuclear neutrophils.
Ninio E; Bessou G
Biochim Biophys Acta; 1991 Aug; 1085(1):136-9. PubMed ID: 1680005
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of platelet activating factor using fast atom bombardment/tandem mass spectrometry.
Haroldsen PE; Gaskell SJ
Biomed Environ Mass Spectrom; 1989 Jun; 18(6):439-44. PubMed ID: 2504312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
